Clinical Trial Update: PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer [NA]

View source ↗

Summary

A clinical trial evaluating sipuleucel-T with PET/MR imaging for metastatic castration-resistant prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer | NA | Status: TERMINATED